127 related articles for article (PubMed ID: 17332242)
1. Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis.
Pinyol M; Bea S; Plà L; Ribrag V; Bosq J; Rosenwald A; Campo E; Jares P
Blood; 2007 Jun; 109(12):5422-9. PubMed ID: 17332242
[TBL] [Abstract][Full Text] [Related]
2. Identification of ARHGEF17, DENND2D, FGFR3, and RB1 mutations in melanoma by inhibition of nonsense-mediated mRNA decay.
Bloethner S; Mould A; Stark M; Hayward NK
Genes Chromosomes Cancer; 2008 Dec; 47(12):1076-85. PubMed ID: 18677770
[TBL] [Abstract][Full Text] [Related]
3. Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma.
Stefancikova L; Moulis M; Fabian P; Ravcukova B; Vasova I; Muzik J; Malcikova J; Falkova I; Slovackova J; Smardova J
Int J Oncol; 2010 Mar; 36(3):699-706. PubMed ID: 20126990
[TBL] [Abstract][Full Text] [Related]
4. Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling.
Beà S; Salaverria I; Armengol L; Pinyol M; Fernández V; Hartmann EM; Jares P; Amador V; Hernández L; Navarro A; Ott G; Rosenwald A; Estivill X; Campo E
Blood; 2009 Mar; 113(13):3059-69. PubMed ID: 18984860
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.
Ripperger T; von Neuhoff N; Kamphues K; Emura M; Lehmann U; Tauscher M; Schraders M; Groenen P; Skawran B; Rudolph C; Callet-Bauchu E; van Krieken JH; Schlegelberger B; Steinemann D
Haematologica; 2007 Apr; 92(4):460-8. PubMed ID: 17488656
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes.
de Leeuw RJ; Davies JJ; Rosenwald A; Bebb G; Gascoyne RD; Dyer MJ; Staudt LM; Martinez-Climent JA; Lam WL
Hum Mol Genet; 2004 Sep; 13(17):1827-37. PubMed ID: 15229187
[TBL] [Abstract][Full Text] [Related]
7. CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus.
Hernández L; Beà S; Pinyol M; Ott G; Katzenberger T; Rosenwald A; Bosch F; López-Guillermo A; Delabie J; Colomer D; Montserrat E; Campo E
Cancer Res; 2005 Mar; 65(6):2199-206. PubMed ID: 15781632
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
9. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.
Wlodarska I; Dierickx D; Vanhentenrijk V; Van Roosbroeck K; Pospísilová H; Minnei F; Verhoef G; Thomas J; Vandenberghe P; De Wolf-Peeters C
Blood; 2008 Jun; 111(12):5683-90. PubMed ID: 18391076
[TBL] [Abstract][Full Text] [Related]
10. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.
Chim CS; Wong KY; Loong F; Lam WW; Srivastava G
Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658
[TBL] [Abstract][Full Text] [Related]
11. p53 and mdm2 in mantle cell lymphoma in leukemic phase.
Solenthaler M; Matutes E; Brito-Babapulle V; Morilla R; Catovsky D
Haematologica; 2002 Nov; 87(11):1141-50. PubMed ID: 12414343
[TBL] [Abstract][Full Text] [Related]
12. BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma.
Bullinger L; Leupolt E; Schaffner C; Mertens D; Bentz M; Lichter P; Döhner H; Stilgenbauer S
Leukemia; 2000 Aug; 14(8):1490-2. PubMed ID: 10942247
[TBL] [Abstract][Full Text] [Related]
13. The ATM gene in the pathogenesis of mantle-cell lymphoma.
Stilgenbauer S; Schaffner C; Winkler D; Ott G; Leupolt E; Bentz M; Möller P; Müller-Hermelink HK; James MR; Lichter P; Döhner H
Ann Oncol; 2000; 11 Suppl 1():127-30. PubMed ID: 10707794
[TBL] [Abstract][Full Text] [Related]
14. The Wnt signaling pathway and mitotic regulators in the initiation and evolution of mantle cell lymphoma: Gene expression analysis.
Kimura Y; Arakawa F; Kiyasu J; Miyoshi H; Yoshida M; Ichikawa A; Niino D; Sugita Y; Okamura T; Doi A; Yasuda K; Tashiro K; Kuhara S; Ohshima K
Int J Oncol; 2013 Aug; 43(2):457-68. PubMed ID: 23760751
[TBL] [Abstract][Full Text] [Related]
15. Lipidoid nanoparticle mediated silencing of Mcl-1 induces apoptosis in mantle cell lymphoma.
Knapp CM; He J; Lister J; Whitehead KA
Exp Biol Med (Maywood); 2016 May; 241(9):1007-13. PubMed ID: 27022142
[TBL] [Abstract][Full Text] [Related]
16. Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.
Enjuanes A; Fernàndez V; Hernández L; Navarro A; Beà S; Pinyol M; López-Guillermo A; Rosenwald A; Ott G; Campo E; Jares P
PLoS One; 2011; 6(5):e19736. PubMed ID: 21603610
[TBL] [Abstract][Full Text] [Related]
17.
Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
[TBL] [Abstract][Full Text] [Related]
18. RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database.
Valverde JR; Alonso J; Palacios I; Pestaña A
BMC Genet; 2005 Nov; 6():53. PubMed ID: 16269091
[TBL] [Abstract][Full Text] [Related]
19. Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 status.
Hassan HM; Varney ML; Chaturvedi NK; Joshi SS; Weisenburger DD; Singh RK; Dave BJ
Leuk Lymphoma; 2016 Dec; 57(12):2874-2889. PubMed ID: 27074052
[TBL] [Abstract][Full Text] [Related]
20. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
Greiner TC; Dasgupta C; Ho VV; Weisenburger DD; Smith LM; Lynch JC; Vose JM; Fu K; Armitage JO; Braziel RM; Campo E; Delabie J; Gascoyne RD; Jaffe ES; Muller-Hermelink HK; Ott G; Rosenwald A; Staudt LM; Im MY; Karaman MW; Pike BL; Chan WC; Hacia JG
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2352-7. PubMed ID: 16461462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
